The global medical digital imaging systems market size was estimated at around USD 15 billion in 2021 and it is projected to hit around USD 30.5 billion by 2030, growing at a CAGR of 8.2% from 2022 to 2030.
Growing demand for advanced imaging solutions with minimal errors and faster results is likely to drive the market during the forecast period. Expanding applications of medical digital imaging in preventive healthcare is poised to contribute to the growth of the market.
Some of the causes of chronic diseases are unhealthy diets, sedentary lifestyles, tobacco and alcohol consumption, and biological factors including dyslipidemia, hypertension, obesity, and hyperinsulinemia. Rising prevalence of various chronic diseases is projected to augment the medical digital imaging market during the forecast period.
Governments of countries such as U.S., U.K., India, and Canada are undertaking initiatives to boost the market. These initiatives are in various forms such as declining import duties for devices, providing favorable policies, and educating physicians & medical imaging device operators. The demand for diagnostic techniques has been increasing in the past few years owing to technological advancements in the field of diagnostics and rising awareness among people regarding early diagnosis of diseases.
Scope of the Report
Report Coverage | Details |
Market Size in 2021 | USD 15 Billion |
Revenue Forecast By 2030 | USD 30.5 Billion |
Growth Rate from 2022 to 2030 | CAGR of 8.2% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Companies Mentioned | Koninklijke Philips N.V, GE Healthcare, Siemens Healthineers, Esaote SPA, Canon Medical Systems Corporation, Hologic, Hitachi, Shimadzu |
Type Insights
Based on the products, the market has been segmented into X-ray, ultrasound systems, CT, MRI, and nuclear imaging. CT accounted for the largest share in the market in 2021 with a 25.2% share. Nuclear imaging is anticipated to be the fastest-growing segment during the forecast period. Development of new radiotracers, increasing prevalence of cancers and cardiovascular diseases, and the introduction of new products through advancements are working in favor of the overall market.
According to the American Cancer Society, 1,762,450 new cancer cases were reported in the U.S. in 2019. Development of radiotracers, such as Single Photon Emission Computed Tomography (SPECT) with technetium 99m radiotracers, which optimizes image quality with reduced radiation exposure, is estimated to contribute to the growth of the CT segment during the forecast period.
Technology Insights
Based on technology, the global medical digital imaging systems market has been bifurcated into 2D and 3D/4D. 2D has been further divided into black and white (BnW) and color. 2D technology captured the largest share in 2017. The 3D technology is expected to witness the highest adoption rate in developed as well as developing regions.
Technological advancements in 3D/4D imaging technology helps in accurate and efficient real-time visualization of human body, thereby minimizing distortion for patients. 4D imaging is 3D with real-time movement. The global market for 3D and 4D devices is likely to experience lucrative growth in the forecast period owing to the increasing adoption of these technologies for fetal monitoring.
Regional Insights
Geographically, the market has been analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominated the market in 2021 owing to the high adoption of advanced technology and improved healthcare infrastructure, high purchasing power, and favorable reimbursement framework.
Asia Pacific is poised to exhibit the highest CAGR with 10.3% during the forecast period, mainly due to increasing government incentives and lower cost of clinical trials. Healthcare in the region is dominated by private healthcare services providers. The presence of international service provider companies such as Wockhardt Hospitals, Columbia Asia, and Fortis Healthcare is projected to boost level of competition in the private sector. Rapid growth in the medical tourism is anticipated to fuel the demand for advanced diagnostic methods in this highly competitive market.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Digital Imaging Systems Market
5.1. COVID-19 Landscape: Medical Digital Imaging Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Digital Imaging Systems Market, By Type
8.1. Medical Digital Imaging Systems Market, by Type, 2022-2030
8.1.1. MRI
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. X-Ray
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Ultrasound
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. CT
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Nuclear Imaging
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Digital Imaging Systems Market, By Technology
9.1. Medical Digital Imaging Systems Market, by Technology, 2022-2030
9.1.1. 2D
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. 3D/4D
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Medical Digital Imaging Systems Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Technology (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Technology (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Technology (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Technology (2017-2030)
Chapter 11. Company Profiles
11.1. Koninklijke Philips N.V
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. GE Healthcare
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Siemens Healthineers
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Esaote SPA
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Canon Medical Systems Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Hologic
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hitachi
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Shimadzu
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms